专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08435715B2 Production method of two-component developer 有权
标题翻译：双组分显影剂的生产方法
公开(公告)号：US08435715B2
公开(公告)日：2013-05-07
申请号：US13185123
申请日：2011-07-18
申请人： Kosuke Nakamura , Hiroyuki Kozuru , Yoshiyasu Matsumoto , Takanari Kayamori , Junya Ueda
发明人： Kosuke Nakamura , Hiroyuki Kozuru , Yoshiyasu Matsumoto , Takanari Kayamori , Junya Ueda
IPC分类号： G03G5/00
CPC分类号： G03G9/107 , G03G9/113 , G03G9/1131 , G03G9/1132 , G03G9/1133
摘要： Disclosed is a production method of a two-component developer for developing an electrostatic image comprising a toner and a resin coated carrier having a porous magnetic core particle and a resin coated layer, wherein the porous magnetic core particle are composed of a porous ferrite material and have pore apertures on a surface of the particle, and the method comprises steps of blocking the pore apertures of the porous magnetic core particle with rubber particles by dry mixing of the porous magnetic core particle and the rubber particles, forming the resin coated carrier by forming a resin layer on the porous magnetic core particle whose pore apertures have been blocked, and mixing the resin coated carrier and the toner.
摘要翻译：公开了一种用于显影静电图像的双组分显影剂的制备方法，所述双组分显影剂包括调色剂和具有多孔磁心颗粒和树脂涂层的树脂涂布载体，其中所述多孔磁性核颗粒由多孔铁氧体材料和在颗粒表面上具有孔隙孔，该方法包括以下步骤：通过干燥多孔磁性核心颗粒和橡胶颗粒的混合，用橡胶颗粒阻挡多孔磁性核颗粒的孔隙，通过形成树脂涂覆载体在多孔磁性核颗粒上的孔隙已经被阻挡的树脂层，并将树脂涂覆的载体和调色剂混合。

2. 发明申请

US20130090482A1 CRYSTALLINE FORMS OF 4, 4'- [4-FLUORO-7-( ETHYNYL)-2-METHYL-1H-INDOLE-1,3-DIYL] DIBUTANOIC ACID, 4,4'-[2-METHYL-7-( ETHYNYL)-1H-INDOLE-1, 3-DIYL] DIBUTANOIC ACID, AND 4,4'-[4-FLUORO-2-METHYL-7- ( ETHYNYL)-1H-INDOLE-1, 3-DIYL] DIBUTANOIC ACID 有权
标题翻译： 4' - [4-氟-7-（乙基）-2-甲基-1H-吲哚-1,3-二基]二苯胺酸的4,4'- [2-甲基-7-（乙基））-1H-吲哚-1,3-二氧化物]二琥珀酸和4,4' - [4-氟-2-甲基-7-（乙基）-1H-吲哚-1,3-二基]二苯胺
公开(公告)号：US20130090482A1
公开(公告)日：2013-04-11
申请号：US13805689
申请日：2011-06-20
申请人： Jun Takeuchi , Satoshi Itadani , Junya Ueda , Shizuka Ono , Takahiro Nekado , Manabu Fujita
发明人： Jun Takeuchi , Satoshi Itadani , Junya Ueda , Shizuka Ono , Takahiro Nekado , Manabu Fujita
IPC分类号： C07D209/24
CPC分类号： C07D209/24 , A61K31/405
摘要： The present invention provides type C crystal of compound I, type B crystal of compound II, or type C crystal of compound III set forth in this specification.
摘要翻译：本发明提供了本说明书中列出的化合物I的C型晶体，化合物II的B型晶体或化合物III的C型晶体。

3. 外观设计

USD602428S1 Assembled battery 有权
公开(公告)号：USD602428S1
公开(公告)日：2009-10-20
申请号：US29301546
申请日：2008-03-06
申请人： Hideki Masuda , Osamu Ushijima , Junya Ueda
设计人： Hideki Masuda , Osamu Ushijima , Junya Ueda

4. 发明授权

US08003642B2 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient 失效
标题翻译：氮化杂环衍生物和包含该衍生物作为活性成分的药剂
公开(公告)号：US08003642B2
公开(公告)日：2011-08-23
申请号：US12282464
申请日：2007-03-09
申请人： Shinya Kusuda , Toshihiko Nishiyama , Kazuya Hashimura , Junya Ueda , Shiro Shibayama
发明人： Shinya Kusuda , Toshihiko Nishiyama , Kazuya Hashimura , Junya Ueda , Shiro Shibayama
IPC分类号： A61K31/5377 , A61K31/4545 , C07D413/14 , C07D401/14
CPC分类号： C07D401/12 , C07D401/14 , C07D417/14 , C07D419/14
摘要： The compound represented by formula (I), a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof specifically binds CCR5, so it is useful for preventing and/or treating CCR5-related diseases, for example, various inflammatory diseases (asthma, nephritis, nephropathy, hepatitis, arthritis, rheumatoid arthritis, rhinitis, conjunctivitis, ulcerative colitis, etc.), immunological diseases (autoimmune diseases, rejection in organ transplantation, immunosuppression, psoriasis, multiple sclerosis, etc.), infectious diseases (infection with human immunodeficiency virus, acquired immunodeficiency syndrome, etc.), allergic diseases (atopic dermatitis, urticaria, allergic bronchopulmonary aspergillosis, allergic eosinophilic gastroenteritis, etc.), ischemic reperfusion injury, acute respiratory distress syndrome, shock accompanying bacterial infection diabetes cancer metastasis and so on Wherein all symbols in formula are as defined in the specification.
摘要翻译：由式（I）表示的化合物，其盐，其N-氧化物，其溶剂合物或其前药特异性结合CCR5，因此其可用于预防和/或治疗CCR5相关疾病，例如各种炎性疾病（哮喘，肾炎，肾病，肝炎，关节炎，类风湿性关节炎，鼻炎，结膜炎，溃疡性结肠炎等），免疫疾病（器官移植中的自身免疫性疾病，排斥反应，免疫抑制，牛皮癣，多发性硬化症等），感染性疾病（人体免疫缺陷病毒感染，获得性免疫缺陷综合征等），过敏性疾病（特应性皮炎，荨麻疹，过敏性支气管肺曲霉病，过敏嗜酸性胃肠炎等），缺血再灌注损伤，急性呼吸窘迫综合征，伴随细菌感染糖尿病的休克癌症转移等等，其中公式中的所有符号如说明书中所定义。

5. 外观设计

USD592129S1 Battery 有权
公开(公告)号：USD592129S1
公开(公告)日：2009-05-12
申请号：US29294820
申请日：2008-01-29
申请人： Hideki Masuda , Osamu Ushijima , Takahiro Shizuki , Yoshitaka Ishida , Junya Ueda , Hiroshi Mukai , Takuji Uchibori
设计人： Hideki Masuda , Osamu Ushijima , Takahiro Shizuki , Yoshitaka Ishida , Junya Ueda , Hiroshi Mukai , Takuji Uchibori

6. 发明申请

US20120028186A1 PRODUCTION METHOD OF TWO-COMPONENT DEVELOPER 有权
标题翻译：双组分开发商的生产方法
公开(公告)号：US20120028186A1
公开(公告)日：2012-02-02
申请号：US13185123
申请日：2011-07-18
申请人： Kosuke NAKAMURA , Hiroyuki KOZURU , Yoshiyasu MATSUMOTO , Takanari KAYAMORI , Junya UEDA
发明人： Kosuke NAKAMURA , Hiroyuki KOZURU , Yoshiyasu MATSUMOTO , Takanari KAYAMORI , Junya UEDA
IPC分类号： G03G9/107
CPC分类号： G03G9/107 , G03G9/113 , G03G9/1131 , G03G9/1132 , G03G9/1133
摘要： Disclosed is a production method of a two-component developer for developing an electrostatic image comprising a toner and a resin coated carrier having a porous magnetic core particle and a resin coated layer, wherein the porous magnetic core particle are composed of a porous ferrite material and have pit apertures on a surface of the particle, and the method comprises steps of blocking the pit apertures of the porous magnetic core particle with rubber particles by dry mixing of the porous magnetic core particle and the rubber particles, forming the resin coated carrier by forming a resin layer on the porous magnetic core particle whose pore openings have been blocked, and mixing the resin coated carrier and the toner.
摘要翻译：公开了一种用于显影静电图像的双组分显影剂的制备方法，所述双组分显影剂包括调色剂和具有多孔磁心颗粒和树脂涂层的树脂涂布载体，其中所述多孔磁性核颗粒由多孔铁氧体材料和在颗粒表面上具有凹坑，该方法包括以下步骤：通过干燥多孔磁性核心颗粒和橡胶颗粒的混合，用橡胶颗粒阻挡多孔磁性核颗粒的凹坑，通过形成在其多孔磁性核颗粒上已经堵塞了孔口的树脂层，并将树脂涂覆的载体和调色剂混合。

7. 外观设计

USD615489S1 Assembled battery 有权
标题翻译：组装电池
公开(公告)号：USD615489S1
公开(公告)日：2010-05-11
申请号：US29316345
申请日：2009-09-15
申请人： Hideki Masuda , Osamu Ushijima , Junya Ueda
设计人： Hideki Masuda , Osamu Ushijima , Junya Ueda

8. 发明申请

US20090131403A1 NITROGENATED HETEROCYCLIC DERIVATIVE , AND PHARMACEUTICAL AGENT COMPRISING THE DERIVATIVE AS ACTIVE INGREDIENT 失效
标题翻译： NITROGENATED HETEROCYCLIC DERIVATIVE，以及包含衍生物作为活性成分的药物代理
公开(公告)号：US20090131403A1
公开(公告)日：2009-05-21
申请号：US12282464
申请日：2007-03-09
申请人： Shinya Kusuda , Toshihiko Nishiyama , Kazuya Hashimura , Junya Ueda , Shiro Shibayama
发明人： Shinya Kusuda , Toshihiko Nishiyama , Kazuya Hashimura , Junya Ueda , Shiro Shibayama
IPC分类号： A61K31/554 , C07D401/14 , A61K31/497 , A61K31/4545 , C07D413/14 , A61K31/5377 , C07D419/14
CPC分类号： C07D401/12 , C07D401/14 , C07D417/14 , C07D419/14
摘要： The compound represented by formula (I), a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof specifically binds CCR5, so it is useful for preventing and/or treating CCR5-related diseases, for example, various inflammatory diseases (asthma, nephritis, nephropathy, hepatitis, arthritis, rheumatoid arthritis, rhinitis, conjunctivitis, ulcerative colitis, etc.), immunological diseases (autoimmune diseases, rejection in organ transplantation, immunosuppression, psoriasis, multiple sclerosis, etc.), infectious diseases (infection with human immunodeficiency virus, acquired immunodeficiency syndrome, etc.), allergic diseases (atopic dermatitis, urticaria, allergic bronchopulmonary aspergillosis, allergic eosinophilic gastroenteritis, etc.), ischemic reperfusion injury, acute respiratory distress syndrome, shock accompanying bacterial infection diabetes cancer metastasis and so on. Wherein all symbols in formula are as defined in the specification
摘要翻译：由式（I）表示的化合物，其盐，其N-氧化物，其溶剂合物或其前药特异性结合CCR5，因此其可用于预防和/或治疗CCR5相关疾病，例如各种炎性疾病（哮喘，肾炎，肾病，肝炎，关节炎，类风湿性关节炎，鼻炎，结膜炎，溃疡性结肠炎等），免疫疾病（器官移植中的自身免疫性疾病，排斥反应，免疫抑制，牛皮癣，多发性硬化症等），感染性疾病（人体免疫缺陷病毒感染，获得性免疫缺陷综合征等），过敏性疾病（特应性皮炎，荨麻疹，过敏性支气管肺曲霉病，过敏嗜酸性胃肠炎等），缺血再灌注损伤，急性呼吸窘迫综合征，伴随细菌感染糖尿病的休克癌转移等。其中公式中的所有符号如说明书中所定义

9. 发明授权

US08598223B2 Crystalline forms of 4, 4′-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl) butoxy] phenyl} ethynyl)-2-methyl-1H-indole-1,3-diyl] dibutanoic acid, 4,4′-[2-methyl-7-({4-[4-(pentafluorophenyl) butoxy] phenyl} ethynyl)-1H-indole-1, 3-diyl] dibutanoic acid, and 4,4′-[4-fluoro-2-methyl-7-({4-[4-(2, 3, 4, 6-tetrafluorophenyl) butoxy] phenyl} ethynyl)-1H-indole-1, 3-diyl] dibutanoic acid 有权
标题翻译： 4,4' - [4-氟-7 - （{4- [4-（3-氟-2-甲基苯基）丁氧基]苯基}乙炔基）-2-甲基-1H-吲哚-1,3- 二丁基]二丁酸，4,4' - [2-甲基-7 - （{4- [4-（五氟苯基）丁氧基]苯基}乙炔基）-1H-吲哚-1,3-二基]二丁酸， 4' - [4-氟-2-甲基-7 - （{4- [4-（2,3,4,6-四氟苯基）丁氧基]苯基}乙炔基）-1H-吲哚-1,3-二基]二丁酸酸
公开(公告)号：US08598223B2
公开(公告)日：2013-12-03
申请号：US13805689
申请日：2011-06-20
申请人： Jun Takeuchi , Satoshi Itadani , Junya Ueda , Shizuka Ono , Takahiro Nekado , Manabu Fujita
发明人： Jun Takeuchi , Satoshi Itadani , Junya Ueda , Shizuka Ono , Takahiro Nekado , Manabu Fujita
IPC分类号： A61K31/405 , A61K31/40 , C07D209/04
CPC分类号： C07D209/24 , A61K31/405
摘要： The present invention provides type C crystal of compound I, type B crystal of compound II, or type C crystal of compound III set forth in this specification.
摘要翻译：本发明提供了本说明书中列出的化合物I的C型晶体，化合物II的B型晶体或化合物III的C型晶体。

10. 外观设计

USD587646S1 Battery 有权
公开(公告)号：USD587646S1
公开(公告)日：2009-03-03
申请号：US29294821
申请日：2008-01-29
申请人： Osamu Ushijima , Hideki Masuda , Takahiro Shizuki , Yoshitaka Ishida , Junya Ueda , Hiroshi Mukai , Takuji Uchibori , Noriyoshi Munenaga
设计人： Osamu Ushijima , Hideki Masuda , Takahiro Shizuki , Yoshitaka Ishida , Junya Ueda , Hiroshi Mukai , Takuji Uchibori , Noriyoshi Munenaga

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式